Sintx Technologies, Inc. - רווח נקי למניה אחת בשנים עשר החודשים האחרונים SINT

Antibacterial ceramics patents and FDA certification create a powerful defensive moat for Sintx Technologies (SINT). The 12-month annual growth in earnings per share demonstrates the dynamics of this advantage, where 67.60 reflects the baseline level of the metric. Success is driven by demand in the aviation and medical sectors, while operational resilience is ensured by the strategic outsourcing of standard blanks while keeping sintering secrets in-house.

This metric measures the dynamics of net earnings per share, allowing for the identification of the gap between GAAP and Non-GAAP reporting to assess real capital sustainability. By analyzing the annual EPS growth rate over the last 12 months, an investor can see how the bioceramic patent protection of Sintx Technologies (SINT) converts into stable financial growth shielded from market volatility.